Transitional Cell Cancer of the Renal Pelvis and Ureter Treatmen - National Cancer Institute

full-text ► patients version ►

Transitional Cell Cancer of the Renal Pelvis and Ureter Treatmen - National Cancer Institute

Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)

• General Information About Transitional Cell Cancer of the Renal Pelvis and Ureter

• Stages of Transitional Cell Cancer of the Renal Pelvis and Ureter

• Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter

• Treatment Option Overview

• Treatment Options for Transitional Cell Cancer of the Renal Pelvis and Ureter

• To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter

• Changes to This Summary (11/14/2013)

• About This PDQ Summary

• Get More Information From NCI

General Information About Transitional Cell Cancer of the Renal Pelvis and Ureter

Key Points for This Section

• Transitional cell cancer of the renal pelvis and ureter is a disease in which malignant (cancer) cells form in the renal pelvis and ureter.
• Misuse of certain pain medicines can affect the risk of transitional cell cancer of the renal pelvis and ureter.
• Possible signs of transitional cell cancer of the renal pelvis and ureter include blood in the urine and back pain.
• Tests that examine the abdomen and kidneys are used to detect (find) and diagnose transitional cell cancer of the renal pelvis and ureter.
• Certain factors affect prognosis (chance of recovery) and treatment options.